While we wait for effective treatments, what else can research deliver for people with dementia?

Written by Clare Walton, Alzheimer’s Society (London, UK)

Driving change with bold ambitions With no way to slow down or stop the diseases that cause dementia and almost 50 million people living with the condition worldwide [1], it is set to be the 21st century’s biggest killer. At the first G8 Summit on dementia in 2013, world leaders made a bold pledge – to find the first disease-modifying treatment by 2025. This shared ambition has sparked a number of positive actions to boost the research landscape, including enhancing international coordination [2,3], review of drug regulation policy [4,5] and significant increases in investment for biomedical research (i.e., US$100 million...

To view this content, please register now for access

It's completely free